Clinical Report: Can external counterpulsation help early Alzheimer disease?
Overview
Full-pressure external counterpulsation (ECP) demonstrated significant cognitive and functional improvements compared to low-pressure treatment in patients with mild cognitive impairment due to Alzheimer disease. The study involved 190 participants over a 12-month period.
Background
Alzheimer disease (AD) is a leading cause of cognitive decline and disability among older adults. Mild cognitive impairment (MCI) due to AD represents an early stage where interventions may be beneficial. External counterpulsation (ECP) has emerged as a non-invasive treatment modality.
Data Highlights
| Outcome Measure | Full-Pressure ECP | Low-Pressure Treatment |
|---|---|---|
| VADAS-cog Score Improvement | 9.95 points | 5.22 points |
| ADAS-cog 14 Score Improvement | 6.16 points | 2.74 points |
| Activities of Daily Living Score Change | +2.57 points | -0.49 points |
| Mini-Mental State Examination Improvement | 1.68 points | 0.19 points |
Key Findings
- Full-pressure ECP resulted in a 9.95-point improvement in VADAS-cog scores compared to 5.22 points in the low-pressure group.
- At 12 months, the full-pressure group showed a 9-point improvement from baseline, while the low-pressure group showed a 3-point decline.
- Activities of daily living scores improved by 2.57 points in the full-pressure group, contrasting with a decline of 0.49 points in the low-pressure group.
- 63% of patients in the full-pressure group had improved or stable scores on both VADAS-cog and ADCS-ADL scales.
- No serious device-related adverse events were reported, with mild skin irritation being the most common issue.
Clinical Implications
The findings suggest that full-pressure ECP may be a viable treatment option for improving cognitive function and daily living activities in patients with early Alzheimer disease. Clinicians should consider the potential benefits of ECP in managing mild cognitive impairment due to Alzheimer disease.
Conclusion
Full-pressure external counterpulsation shows promise as a treatment for cognitive and functional decline in early Alzheimer disease, warranting further investigation into its long-term efficacy and safety.
Related Resources & Content
- Author(s)/Org, Source, Year -- Title
- Frontiers in Psychiatry — Electroacupuncture for treating the cognitive symptoms of Alzheimer’s disease: a randomized controlled trial
- MDSpire News — At-Home Brain Stimulation for Alzheimer’s
- Frontiers in Neurology — Synergistic effects of early sequential enhanced external counterpulsation and electric tilt table training on functional recovery in ischemic stroke: study protocol of a randomized controlled trial
- MDSpire News — Can Brain Stimulation Slow Cognitive Decline?
- Electroacupuncture for treating the cognitive symptoms of Alzheimer’s disease: a randomized controlled trial
- At-Home Brain Stimulation for Alzheimer’s
- Synergistic effects of early sequential enhanced external counterpulsation and electric tilt table training on functional recovery in ischemic stroke: study protocol of a randomized controlled trial
- Clinical Practice Guidelines & Evidence | Alzheimer's Association
- Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial - PubMed
- 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
